Clinical trial

EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma

NCT00006222

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2000-09-01

PhasePHASE1

Study timeline

Study start (unknown)2000-09-01Date precision: month

Registry last updated2013-06-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Sarcomaunresolved

Interventions

cilengitideDRUG

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

NashvilleTennessee, United States1 San FranciscoCalifornia, United States1 La JollaCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00006222 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.